Thats where semaglutide fits in
Semaglutide is typically used for diabetics to help control blood sugar levels, but it has also been found to be incredibly effective in helping adults achieve their weight loss goals
Semaglutide is contraindicated during pregnancy and should be discontinued at least 2 months before a planned pregnancy due to its long half-life
Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic have been shown to be effective in promoting weight loss in adults with obesity, but the long-term effects on weight maintenance are still being studied
They have been assigned to the Ozempic lawsuit overseen by Judge Pratter
However, in the US, UK, and many parts of Europe, the patent protection for semaglutide would last till 2031 and beyond, as they have patent term extension mechanisms that can be used to extend the protection period